BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11839375)

  • 1. PCR-heteroduplex analysis of TCR gamma, delta and TAL-1 deletions in T-acute lymphoblastic leukemias: implications in the detection of minimal residual disease.
    Nirmala K; Rajalekshmy KR; Raman SG; Shanta V; Rajkumar T
    Leuk Res; 2002 Apr; 26(4):335-43. PubMed ID: 11839375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
    Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term follow-up of minimal residual disease in childhood acute lymphoblastic leukemia patients by polymerase chain reaction analysis of multiple clone-specific or malignancy-specific gene markers.
    Kuang S; Gu L; Dong S; Cao Q; Xu C; Huang W; Su XY; Huang QH; Xie JX; Chen SJ; Chen Z
    Cancer Genet Cytogenet; 1996 Jun; 88(2):110-7. PubMed ID: 8640718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
    Sudhakar N; Nancy NK; Rajalekshmy KR; Ramanan G; Rajkumar T
    Am J Hematol; 2007 Mar; 82(3):215-21. PubMed ID: 17133429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence for minimal residual bone marrow disease in children with 'isolated' extra-medullary relapse of T-cell acute lymphoblastic leukemia.
    Neale GA; Pui CH; Mahmoud HH; Mirro J; Crist WM; Rivera GK; Goorha RM
    Leukemia; 1994 May; 8(5):768-75. PubMed ID: 8182934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
    Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ
    Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. tal-1 deletions in T-cell acute lymphoblastic leukemia as PCR target for detection of minimal residual disease.
    Breit TM; Beishuizen A; Ludwig WD; Mol EJ; Adriaansen HJ; van Wering ER; van Dongen JJ
    Leukemia; 1993 Dec; 7(12):2004-11. PubMed ID: 8255100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: comparison with standard morphologic analysis and risk group classification.
    Scrideli CA; Queiroz RG; Bernardes JE; Valera ET; Tone LG
    Med Pediatr Oncol; 2003 Jul; 41(1):10-6. PubMed ID: 12764736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RT/PCR detection of SIL-TAL-1 fusion mRNA in Chinese T-cell acute lymphoblastic leukemia (T-ALL).
    Huang W; Kuang SQ; Huang QH; Dong S; Zhang T; Gu LJ; Ching LM; Chen SJ; Chang LC; Chen Z
    Cancer Genet Cytogenet; 1995 May; 81(1):76-82. PubMed ID: 7773964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
    Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
    Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual T-cell receptor-delta gene rearrangement patterns revealed by screening of a large series of childhood acute lymphoblastic leukaemia by multiplex polymerase chain reaction.
    Seeger K; Taube T; Eckert C; Hanel C; Pogodda M; Henze G
    Br J Haematol; 2001 May; 113(2):318-22. PubMed ID: 11380394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of minimal residual disease: methods and relationship to outcome in T-lineage acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Di Cataldo A; Schilirò G
    Leuk Lymphoma; 1998 Dec; 32(1-2):65-75. PubMed ID: 10037002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia refelct 'end-stage' recombinations: implications for minimal residual disease monitoring.
    Szczepański T; Langerak AW; Willemse MJ; Wolvers-Tettero IL; van Wering ER; van Dongen JJ
    Leukemia; 2000 Jul; 14(7):1208-14. PubMed ID: 10914544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of clonal immunoglobulin heavy chain and I cell receptor gamma gene rearrangements during progression of childhood acute lymphoblastic leukemia.
    Marshall GM; Kwan E; Haber M; Brisco MJ; Sykes PJ; Morley AA; Toogood I; Waters K; Tauro G; Ekert H
    Leukemia; 1995 Nov; 9(11):1847-50. PubMed ID: 7475273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
    Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
    van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
    Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal T-cell receptor gamma and delta gene rearrangements in T-cell acute lymphoblastic leukemia at diagnosis: predictor of prognosis and response to chemotherapy.
    Kode J; Dudhal N; Banavali S; Advani S; Chiplunkar S
    Leuk Lymphoma; 2004 Jan; 45(1):125-33. PubMed ID: 15061208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay.
    Chen X; Pan Q; Stow P; Behm FG; Goorha R; Pui CH; Neale GA
    Leukemia; 2001 Jan; 15(1):166-70. PubMed ID: 11243385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of T cell receptor delta gene rearrangements in childhood B and T lineage acute lymphoblastic leukaemia by southern blot and PCR: technical comparison of two methods of analysis.
    Valetto A; Di Martino D; Scuderi F; Lanza T; Lanciotti M; Bottini F; Dini G
    Clin Lab Haematol; 2000 Oct; 22(5):263-9. PubMed ID: 11122266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.